Single-source·Aug 31, 2026·1 sources analyzed
Trump Reaches Medicaid Drug Price Agreements with Nine Companies
The agreements aim to lower drug prices for Medicaid beneficiaries. Nine pharmaceutical firms have entered into these deals. (sources: Bloomberg.com)
Image: Modern Action subject: Prescription drug prices
Modern Action Briefing
Trump has finalized agreements with nine pharmaceutical companies to reduce drug prices for Medicaid. This initiative is part of broader efforts to manage healthcare costs.
- Nine pharmaceutical firms have agreed to lower drug prices for Medicaid.
- The agreements are intended to benefit Medicaid beneficiaries.
- This initiative is part of ongoing efforts to address healthcare costs.
Why it matters
The agreements may impact the affordability of medications for individuals enrolled in Medicaid.
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Prescription drug prices
See the current decision, choose your position, and send a message through the issue page.
Take action on Prescription drug prices